Traditional Chinese medicine preparation for treating stenocardia, myocardial infarction and preventing in-stent restenosis
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for angina pectoris and restenosis, applied in the field of traditional Chinese medicine, can solve the problems of slow control of symptoms and achieve the effects of preventing hyperlipidemia, reducing blood viscosity, and improving microcirculation
Inactive Publication Date: 2008-08-20
尚小明
View PDF3 Cites 4 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
The traditional treatment method is nothing more than attacking first and then supplementing or supplementing first and then attacking, forcibly relieving pain, treating the symptoms if urgent, and tre
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment approach 1
[0018] Take each bulk drug according to the following weight ratio:
[0024] The medicine of above-mentioned weight is made into 1000mL oral liquid.
Embodiment approach 3
[0026] Take each bulk drug according to the following weight ratio:
[0027] 300g of Danshen, 600g of Astragalus, 240g of Radix Paeoniae Rubra, 240g of Angelica, 180g of Chuanxiong, 180g of peach kernel, 150g of safflower, 210g of leech, 300g of earthworm, 150g of Qingpinxia.
[0028] The medicine of above-mentioned weight is made into 1000mL oral liquid.
[0029] Clinical Trials
[0030] In order to verify the positive effect of the medicine of the present invention, the inventor has carried out a large amount of tests in Tangshan Workers' Hospital and the Affiliated Hospital of North China Coal Medical College, and the selected part of the clinical trial report is as follows. The medicine of the present invention is named "Shenshao Oral Liquid".
[0031] Summary of Clinical Trials of Shenshao Oral Liquid in Treating Angina Pectoris and Myocardial Infarction in 450 Cases
[0032] 1. General Information
[0033] 1. Source of patients: 450 cases were observed in this ex...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a Chinese herbal medicine preparation for curing angina pectoris, myocardial infarction and preventing in-stent restenosis, which is developed by a cardiovascular disease curing expert and President Shang Xiaoming through the understanding of the pathogenesis of chest stuffiness based on traditional Chinese medical science and the combination of modern pharmacological knowledge. The Chinese herbal medicine preparation comprises the following active pharmaceutical ingredients: danshen root, astragalus, red peony root, angelica sinensis, rhizomaligusticichuanxiong, peach kernel, safflower, hirudo, earth worm and rhizoma pinelliae. The drug is compatible with the dialectic theory of Chinese traditional medicine, which has multiple effects of activating blood circulation to dissipate blood stasis, improving blood circulation, nourishing pneuma and benefiting marrow, soothing nerves and promoting intelligence, can expand peripheral vascular, and improve microcirculation, and can prolong the aggregation time of fibrinogen remarkably and inhibit myocardial fibrosis effectively. Thereby, the Chinese herbal medicine preparation has the advantages of low price, good efficacy, no poison and side effect, and broad market prospects.
Description
technical field [0001] The invention relates to a medicine for treating angina pectoris, myocardial infarction and preventing restenosis in a stent, in particular to a traditional Chinese medicine preparation prepared from traditional Chinese medicines, belonging to the field of traditional Chinese medicines. Background of the invention [0002] With the development of society, the pace of life is accelerated, mental stress, obesity, smoking, drinking and other predisposing factors have increased, and the incidence of coronary heart disease in my country has increased significantly in recent years. According to statistics from relevant departments, the average prevalence rate of coronary heart disease About 6.49%, and the prevalence rate increases with age. [0003] Angina pectoris and myocardial infarction are "chest pain" and "true chest pain" in traditional Chinese medicine. At present, the field of traditional Chinese medicine generally believes that acute myocardial infa...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more